|
CENPC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.5029999728996E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.15600004516148E-09 |
| Normal-vs-Stage2 |
2.787400E-04 |
| Normal-vs-Stage3 |
3.62700000033911E-07 |
| Normal-vs-Stage4 |
7.84050000479652E-08 |
| Stage1-vs-Stage2 |
4.289800E-01 |
| Stage1-vs-Stage3 |
7.801800E-01 |
| Stage1-vs-Stage4 |
3.965700E-02 |
| Stage2-vs-Stage3 |
2.978800E-01 |
| Stage2-vs-Stage4 |
3.751600E-02 |
| Stage3-vs-Stage4 |
1.846600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.90729995633399E-09 |
| Normal-vs-AfricanAmerican |
1.07350000000395E-06 |
| Normal-vs-Asian |
3.98129999999997E-05 |
| Caucasian-vs-AfricanAmerican |
4.924600E-01 |
| Caucasian-vs-Asian |
6.634400E-02 |
| AfricanAmerican-vs-Asian |
3.099600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.02550018161219E-10 |
| Normal-vs-Female |
7.68589999999847E-05 |
| Male-vs-Female |
5.976100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.86929999981922E-07 |
| Normal-vs-Extreme_Weight |
8.65630001012363E-09 |
| Normal-vs-Obese |
1.42339999997798E-06 |
| Normal-vs-Extreme_Obese |
2.983300E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.759200E-01 |
| Normal_Weight-vs-Obese |
3.355600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.186400E-01 |
| Extreme_Weight-vs-Obese |
3.093400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.341800E-01 |
| Obese-vs-Extreme_Obese |
6.246400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.93429999999895E-05 |
| Normal-vs-Age(41-60Yrs) |
6.42499999981005E-07 |
| Normal-vs-Age(61-80Yrs) |
4.42019976176766E-10 |
| Normal-vs-Age(81-100Yrs) |
1.01220000003899E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.304400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.835600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.408640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.709700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.611610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.303800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.28280003181192E-09 |
| Normal-VS-Type2 PRCC |
2.850800040477E-09 |
| Normal-VS-KIRP CIMP |
3.40369999995982E-06 |
| Normal-VS-Unclassified PRCC |
4.406700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.995000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.452200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.647000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.873400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.823810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.137000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.92204063565305E-12 |
| Normal-vs-N1 |
2.07309999999961E-06 |
| Normal-vs-N2 |
1.368700E-04 |
| N0-vs-N1 |
3.378000E-01 |
| N0-vs-N2 |
3.777400E-01 |
| N1-vs-N2 |
2.744800E-01 |
|
|
